Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. - Wikidata - wikimedia - TriplyDB

Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence.

Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence.

http://www.wikidata.org/entity/Q35841605

about

DNA methylation age of human tissues and cell types DNA-methylome analysis of mouse intestinal adenoma identifies a tumour-specific signature that is partly conserved in human colon cancer Do breast cancer cell lines provide a relevant model of the patient tumor methylome?A community effort to assess and improve drug sensitivity prediction algorithms.Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer Normal cell-type epigenetics and breast cancer classification: a case study of cell mixture-adjusted analysis of DNA methylation data from tumors.Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients.Human endometrial DNA methylome is cycle-dependent and is associated with gene expression regulation DNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry.Remodeling of the methylation landscape in breast cancer metastasis.Effect of estrogen receptor α binding on functional DNA methylation in breast cancer.Vimentin DNA methylation predicts survival in breast cancer Comparison of clustering methods for investigation of genome-wide methylation array data Whole genome DNA methylation signature of HER2-positive breast cancer MethLAB: a graphical user interface package for the analysis of array-based DNA methylation data.CpGassoc: an R function for analysis of DNA methylation microarray data Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer.FastDMA: an infinium humanmethylation450 beadchip analyzer.DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.Hierarchical clustering of breast cancer methylomes revealed differentially methylated and expressed breast cancer genes.Epigenetic-aging-signature to determine age in different tissues Aberrant methylation of imprinted genes is associated with negative hormone receptor status in invasive breast cancer Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett esophagus.DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer.A DNA hypermethylation module for the stem/progenitor cell signature of cancer.Loss of cell-surface laminin anchoring promotes tumor growth and is associated with poor clinical outcomes.Breast cancer risk and imprinting methylation in blood.Reference-free deconvolution of DNA methylation data and mediation by cell composition effects.Transgelin gene is frequently downregulated by promoter DNA hypermethylation in breast cancer.DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status Epigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancer.Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns Epigenetics as a therapeutic target in breast cancer.Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells DNA methylation and hormone receptor status in breast cancer.Antiestrogen Resistance and the Application of Systems Biology DNA methylation profiling to assess pathogenicity of BRCA1 unclassified variants in breast cancer.Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer.

P2860

Q21183994-39188B0F-B2E6-40B2-99F3-8F40A5121A4F Q27324785-BBB487CB-AEB6-44EE-8791-0F3EFB9B2BD3 Q28542556-A1A78AEE-689F-4499-A098-A859A560FEAE Q30371323-F291AAAD-6388-4B8E-ABE7-B6059AB7A415 Q30408963-F190F71F-92E8-4DB7-B6EE-8F974E43BD53 Q30883752-704B6FAE-2445-4064-90A6-DA5495A46C51 Q30910707-B3734BB3-4BC0-4D11-99D2-2CAFB0AB65F8 Q33821591-4617F0B5-AAD4-48B3-B126-313FAA61F76A Q33893710-B2ABA911-3741-43ED-B13D-04DD15EBAA26 Q33989254-499AB116-FA54-4B85-A3E3-4C89CE416B55 Q34000392-DD47AD46-4F34-4918-BAD3-594EA7203C88 Q34034767-5CE93A59-5209-47B5-A2ED-91DAA23DCCB7 Q34149936-5179AA76-D822-448B-AEA1-C64033BE805E Q34183426-BB41412A-57F2-419C-8FC3-F37FADB59440 Q34202415-3C9EC414-C5CD-4683-B5F4-F808B254674D Q34208767-C7FABF7E-6FB7-4861-8377-B0D670D9666C Q34465725-36BE111F-B16E-4863-B861-7D2B83CA2057 Q34989928-2646028B-EBB1-4F31-A1FD-0DE6725BB328 Q35000317-1AB18804-5DE6-4711-9656-8284BC60F2E3 Q35082784-2D3564B4-D307-49CF-BEF9-4FE01319B722 Q35113247-73ABD8FD-403F-47F6-B927-D01125D34A4F Q35590433-4006B9EE-F68A-49EB-B50D-BE99287CAA85 Q35624942-9CC39EB4-3332-4044-B0C2-C35D04A2FB1C Q35674941-5C0F16D1-21DB-4AAF-B96A-15D311F95084 Q35763885-53599C96-41D2-4DC2-8E34-FA0D143A5C4C Q35888926-93629946-C7E7-4409-9C0E-36BB8D50A79A Q35914847-6F8CA0FD-F33B-428B-8582-13A99ED5168D Q35967522-52A0B119-9430-46A1-A3C5-CFFF9D203414 Q36027913-1018BF31-F61A-4399-A1FD-63E03D1FABB2 Q36064451-B65540D9-E6F3-4A4D-BE02-24EC1BD34E09 Q36105177-8075B9AE-90C0-480F-A51A-131AB33939AE Q36187834-51A5C4C9-51C0-44B6-817F-0DD416B664B5 Q36212916-46938DA9-3DBD-41BA-AD8C-9C58F9856233 Q36378085-437EC998-1DB1-4078-A0D9-E916FA24EF4D Q36449057-3D4AA311-B36C-4F95-B5DE-5C2888C66814 Q36568751-B068610C-B4F7-412D-918F-D49C6EA4A348 Q36583742-FD500558-0646-451C-9B19-F6C1FA589B18 Q36713946-EDFF3628-5135-471E-9DFD-C171A8954BB1 Q36833424-1DF54CE1-C731-4D64-96ED-EAE934BCE872 Q36862682-E41427E2-18EE-4CDB-A4D3-1AAA7D02D525

P2860

Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence.

http://www.wikidata.org/entity/Q35841605

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Genome-wide methylation analys ...... status and risk of recurrence.

@ast

Genome-wide methylation analys ...... status and risk of recurrence.

@en

type

label

Genome-wide methylation analys ...... status and risk of recurrence.

@ast

Genome-wide methylation analys ...... status and risk of recurrence.

@en

prefLabel

Genome-wide methylation analys ...... status and risk of recurrence.

@ast

Genome-wide methylation analys ...... status and risk of recurrence.

@en

P1433

Q35841605-2D89576A-F477-4311-88B1-A0661D87DDBC

P1476

Q35841605-B6EF043B-F612-4A26-A55D-F9FF231A8193

P2093

Q35841605-0D8C200D-73EB-49F1-A519-D96DF1626432

Q35841605-2155A624-0AFB-4888-ACF4-7E3729AF3B0A

Q35841605-29798E5D-3B2C-4C50-8170-6BAB34B1E316

Q35841605-2B06E2A0-6866-4C41-AC75-99D49C0C0944

Q35841605-30527ABF-8D79-4BCE-BA8C-A3DF65A88337

Q35841605-347023B2-6FDE-44EA-8447-AD0F693A8308

Q35841605-5BF9580E-EB47-4ED6-865A-1046D95A4187

Q35841605-624247B7-713D-48DC-B451-2F55F57231F9

Q35841605-6D032A60-7761-43B6-9A93-4469A22E3E80

Q35841605-6DE3A6E0-95E7-4106-AC19-42201936E05A

P2860

Q35841605-0025D619-1143-49FC-B045-AE53D1F37B59

Q35841605-066C9DC9-1B13-4742-BB61-177593137CA3

Q35841605-09DCAB11-62FA-4FA3-9C8D-6ADA3CD118F6

Q35841605-12A0ABDD-36A1-4684-B303-60E7489C0E78

Q35841605-1A701EFA-2DF0-4AE1-9F32-9468DF36C0F7

Q35841605-2774C99C-FB43-4925-8133-B20D0829A626

Q35841605-2CDE0897-9D1B-43AB-B8CD-2107DE798F30

Q35841605-2DB7863F-AA1F-402C-95D1-4650C2311620

Q35841605-2FABDF59-FAD5-4BF8-9013-754BE22017E4

Q35841605-35782D8E-E32F-4A7A-BDC1-5DC9E18742D0

P304

Q35841605-39E6E573-913A-4872-B279-175E028D1AFB

P31

Q35841605-2E42B20F-1541-4ACA-85B1-97EC65EA2CDB

P356

Q35841605-F06B65B8-B5FE-4104-9E34-6FDC1B232F69

P407

Q35841605-3705FD8E-41FB-4F9E-8B03-B10C23540370

P433

Q35841605-DC0B257C-7E28-4CC7-9100-A5CFA46383F0

P478

Q35841605-76D4D19C-96A7-491A-A4CB-E5BE32D6F65E

P577

Q35841605-D3F1F495-88D5-49DE-A52E-7A0C947C4529

P5875

Q35841605-5F7CF0F7-DAD8-4EC1-BFE0-D79DD47C4B1A

P698

Q35841605-27110EB9-4DDE-46F1-BC8D-6B2F2B86D086

P932

Q35841605-CCD1059B-5433-476E-A5F4-B8A1FA84C288

P356

0008-5472.CAN-11-1630

P1433

Cancer Research

P1476

Genome-wide methylation analys ...... status and risk of recurrence.

@en

P2093

Antonio C Wolff

http://www.w3.org/2001/XMLSchema#string

Christopher B Umbricht

http://www.w3.org/2001/XMLSchema#string

Danielle Williams

http://www.w3.org/2001/XMLSchema#string

Jeffrey Marks

http://www.w3.org/2001/XMLSchema#string

Joe W Gray

http://www.w3.org/2001/XMLSchema#string

Kala Visvananthan

http://www.w3.org/2001/XMLSchema#string

Leigh-Ann Cruz

http://www.w3.org/2001/XMLSchema#string

Leslie M Cope

http://www.w3.org/2001/XMLSchema#string

Mary Jo Fackler

http://www.w3.org/2001/XMLSchema#string

Pedram Argani

http://www.w3.org/2001/XMLSchema#string

P2860

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers

The consensus coding sequences of human breast and colorectal cancers

The genomic landscapes of human breast and colorectal cancers

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Breast cancer. Clinical practice guidelines in oncology

Epigenetics in cancer

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Quantitative assessment of promoter hypermethylation during breast cancer development

Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.

P304

6195-6207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-11-1630

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51555418

http://www.w3.org/2001/XMLSchema#string

P698

21825015

http://www.w3.org/2001/XMLSchema#string

P932

3308629

http://www.w3.org/2001/XMLSchema#string